Yoshihito Morimoto
6PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 09, 2025
Sustained antiemetic efficacy of fosnetupitant versus aprepitant in carboplatin-based chemotherapy: a retrospective observational study.Hiroshi Inano, Yoshihito Morimoto, Atsushi Kawamura
|Feb 04, 2025
Cost-effectiveness analysis of fosnetupitant in patients receiving cisplatin in Japan: analysis based on real-world data.Hiroshi Inano, Yoshihito Morimoto, Kanata Kitagawa
|Sep 22, 2022
Simultaneous inhibition of Chk1 and Bcl-xL induces apoptosis in vitro and represses tumour growth in an in vivo xenograft model.Yoshihito Morimoto, Kimihiko Takada, Osamu Takeuchi
|Jun 23, 2020
Bcl-2/Bcl-xL inhibitor navitoclax increases the antitumor effect of Chk1 inhibitor prexasertib by inducing apoptosis in pancreatic cancer cells via inhibition of Bcl-xL but not Bcl-2.Yoshihito Morimoto, Kimihiko Takada, Osamu Takeuchi
|Oct 06, 2018
Risk factors for venous irritation in patients receiving vinorelbine: a retrospective study.Yoshihito Morimoto, Kumika Miyawaki, Reisuke Seki
|Nov 28, 2017
Joint symptoms associated with anastrozole and letrozole in patients with breast cancer: a retrospective comparative study.Yoshihito Morimoto, Shuhei Sarumaru, Yuko Oshima
Pageof 1
